发明名称 QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a novel compound that inhibits the chronic progression of Parkinson's disease or protects dopamine neurons from disease etiology thereof, thereby suppressing the progression of neurological dysfunction, so as to prolong the period of time until L-dopa is administered, while improving functions. ! SOLUTION: A quinolone compound of the invention is represented by the formula (1), where: R1 represents hydrogen or the like; R2 represents hydrogen or the like; R3 represents a phenyl group that may have a substituent, or the like; R4 represents halogen or the like; R5 represents hydrogen or the like; R6 represents hydrogen or the like; and R7 represents hydrogen or the like. ! COPYRIGHT: (C)2015,JPO&INPIT
申请公布号 JP2015157836(A) 申请公布日期 2015.09.03
申请号 JP20150085167 申请日期 2015.04.17
申请人 OTSUKA PHARMACEUT CO LTD 发明人 OTSUBO KENJI ; YAMAUCHI TAKAHITO ; OCHI YUJI
分类号 C07D215/26;A61K31/47;A61K31/473;A61K31/4741;A61K31/4745;A61K31/496;A61K31/506;A61K31/5377;A61K31/551;A61K31/553;A61K31/661;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P7/06;A61P9/00;A61P11/00;A61P13/12;A61P25/00;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P27/02;A61P27/16;A61P37/04;A61P37/06;A61P39/02;A61P43/00;C07D221/06;C07D221/10;C07D401/04;C07D401/06;C07D401/12;C07D405/04;C07D409/04;C07D413/14;C07D471/04;C07D491/048;C07D491/052;C07F9/09 主分类号 C07D215/26
代理机构 代理人
主权项
地址